MedTrace Logo

MISSION Severe Asthma Modern Innovative Solutions to Improve Outcomes in Severe Asthma.

NCT02509130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2016-09-27

No results posted yet for this study

Summary

MISSION is a new and novel way of delivering highly specialised asthma care and has the potential to change the way asthma care across the United Kingdom (UK) is delivered as well as services for other long term health conditions. The MISSION model is the first model of this type and the current research study aims to evaluate its success and to compare the MISSION service to current care delivery. This will be done in several different ways. The study is a mixed methods evaluation of the new service comparing outcomes before and after the intervention using retrospective data analysis and prospective qualitative interview. A control arm of patients not exposed to, but eligible for, the new intervention will also be included. The study will be conducted at Portsmouth Hospitals National Health Service (NHS) Trust and will recruit patients who attended MISSION clinics, outpatient asthma clinics, staff who attended MISSION clinics in a professional capacity and patients from GP surgeries where MISSION clinics were held who did not attend.

Conditions

Sponsors & Collaborators

  • University of Portsmouth

    collaborator OTHER

  • Portsmouth Hospitals NHS Trust

    lead OTHER_GOV

Principal Investigators

  • Professor Anoop J Chauhan · Portsmouth Hospitals NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02509130 on ClinicalTrials.gov